Stable knockdown of MYCN by lentivirus-based RNAi inhibits human neuroblastoma cells growth in vitro and in vivo

Biochemical and Biophysical Research Communications

Volumn 410, Issue 2, 2011, Pages 364-370

  Jiang, Richeng ^a   Xue, Sufang ^b   Jin, Ziliang ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Lentivirus; MYCN; Neuroblastoma; RNAi shRNA

Indexed keywords

CASPASE 3; LENTIVIRUS VECTOR; PROTEIN; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN MYCN; PROTEIN P27; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL DIFFERENTIATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; EXPRESSION VECTOR; GENE EXPRESSION; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; TREATMENT OUTCOME; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; LENTIVIRUS; MICE; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; RNA INTERFERENCE;

LENTIVIRUS;

EID: 79959703462     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.06.020     Document Type: Article

References (22)

1. Maris J.M., Matthay K.K. Molecular biology of neuroblastoma. J. Clin. Oncol. 1999, 17:2264-2279.
2. Small M.B., Hay N., Schwab M., Bishop J.M. Neoplastic transformation by the human gene N-myc. Mol. Cell. Biol. 1987, 7:1638-1645.
3. Weiss W.A., Aldape K., Mohapatra G., Feuerstein B.G., Bishop J.M. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J. 1997, 16:2985-2995.
4. Rosolen A., Whitesell L., Ikegaki N., Kennett R.H., Neckers L.M. Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line. Cancer Res. 1990, 50:6316-6322.
5. Burkhart C.A., Cheng A.J., Madafiglio J., Kavallaris M., Mili M., Marshall G.M., Weiss W.A., Khachigian L.M., Norris M.D., Haber M. Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma. J. Natl. Cancer Inst. 2003, 95:1394-1403.
6. Tonelli R., Purgato S., Camerin C., Fronza R., Bologna F., Alboresi S., Franzoni M., Corradini R., Sforza S., Faccini A., Shohet J.M., Marchelli R., Pession A. Anti-gene peptide nucleic acid specifically inhibits MYCN expression in human neuroblastoma cells leading to cell growth inhibition and apoptosis. Mol. Cancer Ther. 2005, 4:779-786.
7. Kang J.H., Rychahou P.G., Ishola T.A., Qiao J., Evers B.M., Chung D.H. MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells. Biochem. Biophys. Res. Commun. 2006, 351:192-197.
8. Nara K., Kusafuka T., Yoneda A., Oue T., Sangkhathat S., Fukuzawa M. Silencing of MYCN by RNA interference induces growth inhibition, apoptotic activity and cell differentiation in a neuroblastoma cell line with MYCN amplification. Int. J. Oncol. 2007, 30:1189-1196.
9. Woo C.W., Tan F., Cassano H., Lee J., Lee K.C., Thiele C.J. Use of RNA interference to elucidate the effect of MYCN on cell cycle in neuroblastoma. Pediatr. Blood Cancer 2008, 50:208-212.
10. Khvorova A., Reynolds A., Jayasena S.D. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003, 115:209-216.
11. Moffat J., Grueneberg D.A., Yang X., Kim S.Y., Kloepfer A.M., Hinkle G., Piqani B., Eisenhaure T.M., Luo B., Grenier J.K., Carpenter A.E., Foo S.Y., Stewart S.A., Stockwell B.R., Hacohen N., Hahn W.C., Lander E.S., Sabatini D.M., Root D.E. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006, 124:1283-1298.
12. Schwarz D.S., Hutvagner G., Du T., Xu Z., Aronin N., Zamore P.D. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003, 115:199-208.
13. Szulc J., Wiznerowicz M., Sauvain M.O., Trono D., Aebischer P. A versatile tool for conditional gene expression and knockdown. Nat. Methods 2006, 3:109-116.
14. Jiang R., Cabras G., Sheng W., Zeng Y., Ooka T. Synergism of BARF1 with Ras induces malignant transformation in primary primate epithelial cells and human nasopharyngeal epithelial cells. Neoplasia 2009, 11:964-973.
15. Pession A., Tonelli R. The MYCN oncogene as a specific and selective drug target for peripheral and central nervous system tumors. Curr. Cancer Drug Targets 2005, 5:273-283.
16. Negroni A., Scarpa S., Romeo A., Ferrari S., Modesti A., Raschella G. Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line. Cell Growth Differ. 1991, 2:511-518.
17. Cho J.G., Kim M.K., Oh E.J., Yoon E.J., Sohn J., Park M.K., Park G.H. Pharmacokinetics of (111)In-labeled triplex-forming oligonucleotide targeting human N-myc gene. Mol. Cells 2002, 14:93-100.
18. Pession A., Tonelli R., Fronza R., Sciamanna E., Corradini R., Sforza S., Tedeschi T., Marchelli R., Montanaro L., Camerin C., Franzoni M., Paolucci G. Targeted inhibition of NMYC by peptide nucleic acid in N-myc amplified human neuroblastoma cells: cell-cycle inhibition with induction of neuronal cell differentiation and apoptosis. Int. J. Oncol. 2004, 24:265-272.
19. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498.
20. Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002, 296:550-553.
21. Lee N.S., Dohjima T., Bauer G., Li H., Li M.J., Ehsani A., Salvaterra P., Rossi J. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 2002, 20:500-505.
22. Rubinson D.A., Dillon C.P., Kwiatkowski A.V., Sievers C., Yang L., Kopinja J., Rooney D.L., Zhang M., Ihrig M.M., McManus M.T., Gertler F.B., Scott M.L., Van Parijs L. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 2003, 33:401-406.